The clinical information you need, at your fingertips.

Latest ACS guidance adds multitarget stool RNA testing while cautioning that blood-based screening should be reserved for patients unwilling to complete preferred tests. . .

Randomized phase 2 data suggest androgen receptor inhibitors may differ meaningfully in cognitive effects and tolerability. . .

In adults without cardiovascular disease, better pre-pandemic heart health didn't change who caught COVID-19 but it did track with who got severely ill. . .

Trained on 30,000+ cancer genomes, a model read the full mutation profile rather than single biomarkers to predict checkpoint inhibitor survival in three cancer types. Performance matched or beat other outcome prediction methods. . .

Microbial and metabolic features partly resembling those seen in colorectal cancer were still detectable in women an average of 12 years after adenoma resection, suggesting the gut doesn't return to a low-risk state and pointing to lifestyle as a possible lever. . .

FDA alert highlights potential for hyperglycemia and DKA from affected Omnipod systems. . .

Adding the vitamin C–rich fruit to supplements led to larger hemoglobin gains than supplements alone, a meta-analysis of Indonesian studies found. . .

Adapalene and benzoyl peroxide combination therapy becomes the first prescription-strength retinoid–benzoyl peroxide acne gel available without a prescription. . .

Phase 3 trial finds ecopipam reduced relapse risk and avoided many adverse effects tied to current antipsychotic therapies. . .